Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

AAV based gene therapy	3
Gene therapy	2
Gene editing	2
Fusion protein	1

Top 5 Target	Count

ABCA4(ATP binding cassette subfamily A member 4)	1
RP4(Rhodopsin)	1
CYP4V2(cytochrome P450 family 4 subfamily V member 2)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 13 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 2

Phase 3

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

ZVS-101e ( CYP4V2 )	Bietti Crystalline Dystrophy More	Phase 3
ZVS-203e ( RP4 )	Retinitis Pigmentosa More	Phase 1/2
ZVC-105e	Retinitis Pigmentosa More	Preclinical
ZVS-204e	Retinitis Pigmentosa More	Preclinical
ZVS-106e	Stargardt Disease More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis